Dosing Begins in Phase 3 Trial of PET Agent for Parkinsonian Syndromes

The first patient has been dosed in a Phase 3 trial testing GE Healthcare’s new dopamine transporter positron emission tomography (PET) tracer, which is designed to aid in the evaluation of adults with suspected parkinsonian syndromes, including Parkinson’s disease. The PET agent is a…

The Early Signs of Parkinson’s That My Sister Experienced

We encounter signs almost every day of our lives. Traffic lights tell us when to stop or go, and road signs tell us which exit to take. Turn signals (when used) let us know if the car in front of us is turning left or right. Dark clouds in the…

Brain Changes Might Predict Parkinson’s Mild Cognitive Impairment

Early atrophy of a speech-related brain area called temporal lobe and progressive degeneration of a cognitive one (frontal lobe) might be warning signs for Parkinson’s mild cognitive impairment later on, researchers report. Their study, “Progressive brain atrophy in Parkinson’s disease patients who convert to mild cognitive impairment,” was…